Human stem cell therapy could be on market in four years, researcher says

Oct 5, 2010

If trials on humans go the way they did on rats and pigs, a stem cell therapy to treat patients with Lou Gehrig’s disease could be on the market in four years…

Recent Posts

Stem cell model replicates human amniotic sac development past two weeks
Infant becomes world’s first patient to undergo personalized gene-editing treatment
Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
Embryonic macrophages found to control blood stem cell numbers in bone marrow
Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
The stem cell race for Parkinson’s disease: Recent studies show significant promise